Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article reviews various aspects of shampoos, including preparation methods and commercial value, but reports no new experimental results, instead focusing on patents and product evaluation criteria.

This review compiles patents for nanoparticulate drug delivery systems, discussing preparation methods, therapeutic applications, and commercialization, but reports no new experimental results.

This review explores the unclear rationale behind excluding medical treatment methods from patentability and the complexities of allowing medical indication patents, offering potential solutions but reporting no new results.

This chapter discusses the process from ideation to patent and licensure for biotechnologies, offering an introduction to the intersection of business, law, and biotechnology without reporting new results.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

This article reviews the conflicting approaches to patentability of dosage regimen inventions under Chinese law and reports no resolution on which position Chinese courts will adopt.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

This study reports that novel hexahydrobenzoquinolin compounds fully inhibited 5α-reductase activity in human genital skin fibroblasts, suggesting their potential for treating conditions like benign prostatic hyperplasia and male pattern baldness.

This study reports the development of novel 4-amido-Δ4,6-steroids as potential inhibitors of 5α-reductase, showing promising in vitro results for conditions like acne and benign prostatic cancer.

This study validated a new test method using a patented chamber to measure the efficacy of a sunscreen in reducing carbon black particle adhesion, with a 55% reduction observed on treated skin in a group of 22 women.

This study reports that men with androgenic alopecia experience altered neuroactive steroid levels associated with persistent depression symptoms even after stopping finasteride treatment.

This study found that illness perception, as measured by the Revised Illness Perception Questionnaire, was significantly associated with health-related quality of life in patients with primary cutaneous T- and B-cell lymphomas.

This study suggests that a larger prostate is associated with a higher prevalence of androgenetic alopecia, although the prostate size did not correlate with alopecia severity.

This systematic review reports that for patients with underlying dermatologic disorders who contracted COVID-19, most experienced mild to moderate exacerbation of their skin conditions and were managed similarly to the general population, suggesting treatment discontinuation during acute infection may prevent severe recurrence.

The authors concluded that some patients clinically diagnosed with telogen effluvium may actually have alopecia areata incognita, suggested by the presence of dystrophic hairs and development of alopecia patches.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

This study observed that oral mTOR inhibitors frequently cause dermatological side effects, such as mouth ulcers and acneiform eruptions, but these rarely require stopping the treatment.

People with vitiligo may have a lower risk of heart disease.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Patients with Polycystic Ovary Syndrome in this study had significantly higher anxiety and depression scores compared to controls, but showed no significant differences in temperament and character traits.

In this study, patients with larger prostates were observed to have a higher prevalence of androgenetic alopecia.

The researchers highlighted the need for empathetic and caring healthcare professionals for alopecia patients, recommending enhanced training for general practitioners and improved coordination between primary and secondary care pathways.

Patients with Focal Dermal Hypoplasia often experience skin, nail, hair, and bone issues, and may benefit from calcium and vitamin D supplements.

This study assessed patient satisfaction and hair retention in 15 individuals with alopecia treated with Biofibre ® 4.0 artificial hair implants, finding high levels of satisfaction and excellent biocompatibility, with no significant adverse reactions reported after one year.

This study found that patients with alopecia have limited knowledge, negative attitudes, and proactive practices toward the condition, influenced by factors such as age, COVID-19, medication, and polycystic ovary syndrome, suggesting that improving knowledge through education may enhance patient management.

Psoriasis patients should do moderate exercise like walking or yoga for 30 minutes, 4-5 times a week.

In this study, patients with severe alopecia areata treated with baricitinib over 152 weeks experienced sustained patient-reported improvements in scalp, eyebrow, and eyelash hair regrowth, with higher responders observed in the 4mg dose group compared to the 2mg group.

This study reports that cancer patients experiencing chemotherapy-induced alopecia actively engage in Facebook groups for support, instructions, and product recommendations related to scalp cooling, but only 5% consult dermatologists for hair loss concerns, highlighting the platform's influence on patient treatment decisions.